Abstract:Hepatocellular carcinoma (HCC) is the second leading cause of cancer death worldwide. Advanced HCC has proven particularly difficult to treat because of a scarcity of clear genetic drivers of cancer progression; thus, there are currently no predictive markers that guide HCC therapy. HCC arises in the context of co-morbid hepatitis due to hepatitis B virus (HBV), hepatitis C (HCV) or fatty liver disease. We hypothesize that protein-protein interactions (PPIs) between viral proteins and HCC genes may contribute to tumor initiation and maintenance. In order to characterize these PPIs, we performed affinity purification - mass spectrometry (APMS), defining 145 HBV/host PPIs including known and novel interacting partners. We next used a network propagation algorithm to identify host genes and protein complexes that were preferentially mutated in the absence of HBV infection. HBV is a small DNA virus, with 4 genes of which only one has enzymatic activity, raising a question as to how HBV interaction modifies host behavior. Using AP-MS of host proteins, we found that the HBV X protein (HBx) remodels multiple host protein complexes through direct interaction. These physical effects on complex components result in distinct biochemical behavior from the CRL4 E3 ubiquitin ligase complex as well as the phosphatase PP2A, as determined through global phosphoproteomics and ubiquitin analysis. We show that this remodeling driven by HBx substantially changes cellular protein turnover and downstream signaling dynamics. We followed this up with assessments of cellular viability and proliferation in response to pharmacological inhibition or CRISPRi-based knockdown of HBx effectors. Our data support a model where HBV proteins alter the components and behavior of key regulatory protein complexes in the cell, altering tumor behavior and raising the possibility of precision therapeutics for HCC. Citation Format: John D. Gordan, Adriana Pitea, Manon Eckhardt, Gwendolyn Jang, Rigney E. Turnham, Alex L M. Choi, John Von Dollen, Huat C. Lim, Elizabeth F. Thayer, R. Katie Kelley, Danielle L. Swaney, Wei Zhang, Fabian J. Theis, Trey Ideker, Nevan J. Krogan. Hepatitis B virus remodels host protein interaction networks to generate distinct cellular dependencies [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 4891.

Major Vault Protein Promotes Hepatocellular Carcinoma Through Targeting Interferon Regulatory Factor 2 and Decreasing P53 Activity

Major vault protein regulates tumor-associated macrophage polarization through interaction with signal transducer and activator of transcription 6

HBV Rewires Liver Cancer Signaling by Altering PP2A Complexes

Hepatitis C virus NS3 protein enhances hepatocellular carcinoma cell invasion by promoting PPM1A ubiquitination and degradation

14-3-3Ε Boosts Bleomycin-induced DNA Damage Response by Inhibiting the Drug-resistant Activity of MVP

Abstract 4891: Hepatitis B Virus Remodels Host Protein Interaction Networks to Generate Distinct Cellular Dependencies

Hepatitis B Virus X Protein Inhibits P53-Mediated Upregulation of Mitofusin-2 in Hepatocellular Carcinoma Cells

MVP enhances FGF21-induced ferroptosis in hepatocellular carcinoma by increasing lipid peroxidation through regulation of NOX4

VCP Interaction with HMGB1 Promotes Hepatocellular Carcinoma Progression by Activating the PI3K/AKT/mTOR Pathway

Effects of Hepatitis B Virus on P53 Expression in Hepatoma Cell Line SMMU-7721

Interaction Effect of P53 with HBV in Hepatoma Cell Line SMMC-7721

Major vault protein suppresses obesity and atherosclerosis through inhibiting IKK-NF-κB signaling mediated inflammation

HBV Remodels PP2A Complexes to Rewire Kinase Signaling in Hepatocellular Carcinoma

Novel roles of Vmp1: inhibition metastasis and proliferation of hepatocellular carcinoma.

Major Vault Protein is a Direct Target of Notch1 Signaling and Contributes to Chemoresistance in Triple-Negative Breast Cancer Cells.

Deficiency of the promyelocytic leukemia protein fosters hepatitis C-associated hepatocarcinogenesis in mice

Hepatitis B Virus X Protein Increases Microrna-21 Expression and Accelerates the Development of Hepatoma Via the Phosphatase and Tensin Homolog/Phosphoinositide 3-Kinase/protein Kinase B Signaling Pathway

Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein

P53 Promotes Proteasome-Dependent Degradation of Oncogenic Protein HBx by Transcription of MDM2.

Interaction of P53 with P53 Response Element Like Binding Sequence at Upstream of Hepatitis B Virus Enhancer I

Overexpression of HGF Promotes HBV-Induced Hepatocellular Carcinoma Progression and is an Effective Indicator for Met-Targeting Therapy.